Rapport Therapeutics (RAPP) Depreciation and Depletion (2023 - 2026)
Rapport Therapeutics' (RAPP) quarterly Depreciation and Depletion came in at $200000.0 in Q1 2026, little changed year-on-year from $200000.0 in Q1 2025, and little changed on a QoQ basis from $200000.0 in Q4 2025.
Rapport Therapeutics (RAPP) Depreciation and Depletion (2023 - 2026) Analysis & Trends
Rapport Therapeutics (RAPP) has 4 years of Depreciation and Depletion data on file, last reported at $200000.0 in Q1 2026.
- On a quarterly basis, Depreciation and Depletion changed 0.0% year-over-year to $200000.0 in Q1 2026; TTM through Mar 2026 was $1.0 million, a 25.0% increase from a year earlier, with the FY2025 full-year figure at $1.0 million, up 25.0% from the prior year.
- Depreciation and Depletion for Q1 2026 stood at $200000.0, roughly flat from $200000.0 in the prior quarter.
- Over the last five years, Depreciation and Depletion for RAPP reached as high as $300000.0 in Q2 2025 and fell as low as $23000.0 in Q3 2023.
- Historically, Depreciation and Depletion has averaged $180333.3 across 4 years, with a median of $200000.0 in 2024.
- Across the five-year window, Depreciation and Depletion jumped 769.57% in 2024 and changed 0.0% in 2025, its largest moves.
- Year by year, Depreciation and Depletion stood at $41000.0 in 2023, then jumped by 387.8% to $200000.0 in 2024, then changed by 0.0% to $200000.0 in 2025, then changed by 0.0% to $200000.0 in 2026.
- Per Business Quant data, the three most recent Depreciation and Depletion figures were $200000.0 in Q1 2026, $200000.0 in Q4 2025, and $300000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 39.39 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Rapport Therapeutics | 1.95 Bn | 1.95 Bn | - | 200,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 200,000.00 |
| Mar 31, 2026 | 200,000.00 |
| Dec 31, 2025 | 200,000.00 |
| Dec 31, 2025 | 200,000.00 |
| Sep 30, 2025 | 300,000.00 |
| Sep 30, 2025 | 300,000.00 |
| Jun 30, 2025 | 300,000.00 |
| Jun 30, 2025 | 300,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Dec 31, 2024 | 200,000.00 |
| Dec 31, 2024 | 200,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Jun 30, 2024 | 200,000.00 |
| Jun 30, 2024 | 200,000.00 |
| Mar 31, 2024 | 200,000.00 |
| Mar 31, 2024 | 200,000.00 |
| Dec 31, 2023 | 41,000.00 |
| Dec 31, 2023 | 41,000.00 |